These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 548482)

  • 1. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. Second report: Urinary fibrin/fibrinogen degradation products in nephrotic syndrome. (author' transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):315-26. PubMed ID: 671855
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrin and fibrinogen degradation products in the urine of patients with nephrotic syndrome].
    Ena IaM
    Sov Med; 1975 Jul; (7):85-9. PubMed ID: 1216058
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on fibrinolytic therapy in children with various renal diseases with special reference to changes of urinary FDP x D-dimer fragments].
    Kamitsuji H; Iida Y; Omura R; Taira K; Tsukada S; Kusumoto K; Okamoto Y
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1251-9. PubMed ID: 7166891
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
    Bouissou F; Barthe P; Boneu B
    Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
    [No Abstract]   [Full Text] [Related]  

  • 14. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 16. [The kidney and fibrinolysis. (2) Urinary excretion of FDP].
    Taura K; Fukushima K; Shinzato K; Harada T; Ogata H
    Nihon Jinzo Gakkai Shi; 1977 Mar; 19(3):139-49. PubMed ID: 560577
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
    Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
    Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rHuEPO increases urinary excretion of fibrin degradation products in haemodialysed patients.
    Gareau R; Gagnon MG; Ayotte C; Chénard C; Brisson GR
    Thromb Haemost; 1993 Aug; 70(2):373-4. PubMed ID: 8236152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.